Betaseron Articles
POOR PERFORMANCE BY SCHERING AG IN 1st QTR
10 May 1993
EUROPE STOCK COMMENT
29 March 1993
FDA PANEL ENDORSES BERLEX' BETASERON
29 March 1993
SCHERING AG ISSUES WARNING FOR 1993
29 March 1993
CHIRON'S BETASERON
8 March 1993
SCHERING AG GENTECH IN USA
18 January 1993
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
